ZP
Zeenat Parvin
About Zeenat Parvin
Data last updated:
Zeenat Parvin has experience in corporate governance. Holds Additional Director role. Currently with 1 company, including Bardhaman Institute Of Medical Science Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Bardhaman Institute Of Medical Science Private Limited at ₹19.18 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 01 Nov 2025 | 2014 | ₹19.18 Cr (FY 2024) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Zeenat Parvin
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zeenat Parvin
Zeenat Parvin has experience in corporate governance. Holds Additional Director role. Currently with 1 company, including Bardhaman Institute Of Medical Science Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Bardhaman Institute Of Medical Science Private Limited at ₹19.18 Cr (FY 2024).
Zeenat Parvin is associated with 1 company as Additional Director, including Bardhaman Institute Of Medical Science Private Limited (₹19.18 Cr).
Zeenat Parvin has expertise in General Business.
Zeenat Parvin has extensive experience in corporate governance.
By reported revenue, the largest current company of Zeenat Parvin is Bardhaman Institute Of Medical Science Private Limited, with revenue of ₹19.18 Cr (FY 2024).
Zeenat Parvin currently holds positions at 1 company: Bardhaman Institute Of Medical Science Private Limited (₹19.18 Cr).